… Universal vaccination of children 6 to 59 months of age with trivalent inactivated influenza
vaccine … To evaluate alternative vaccine approaches, we compared the safety and efficacy of …

… vaccine and recommended its use in children from 2–18 years of age. Although this new live
attenuated influenza vaccine … humans, compare trivalent inactivated influenza vaccine (TIV) …

… , leading to consideration of including anti-NA antibody assays in vaccine evaluations (15).
The poor physical stability of NA limits its utility in inactivated influenza vaccines (16). …

… In this case, a diagnosis of multiple sclerosis unrelated to vaccination was made. Other studies
[25, 26] have indicated that vaccination with inactivated influenza vaccine does not exacer…

… the morbidity and mortality associated with influenza. The US Advisory Committee on …
influenza vaccination for all children aged 6 months and older since 2008. Inactivated influenza …

… for whom either vaccine was … : the inactivated influenza vaccine or matching placebo (physiologic
saline) administered by intramuscular injection or the live attenuated influenza vaccine …

… influenza vaccines (LAIV) and inactivated influenza vaccines (IIV) induce protective immunity
against influenza… Live attenuated versus inactivated influenza vaccine in infants and young …

… Researchers in observational studies of vaccine effectiveness (VE) in which they compared
quadrivalent live attenuated vaccine (LAIV4) and inactivated influenza vaccine (IIV) among …

… vaccination with an inactivated influenza vaccine. However, we found that intranasal
administration of a concentrated, whole inactivated influenza virus vaccine … for seasonal influenza …

… 1 dose of the 2009 seasonal trivalent inactivated influenza vaccine (TIV). Blood samples
were collected before vaccination (day 0) and on day 7 or 8 and approximately day 28 after …